Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

NASDAQ:BYRN - Nasdaq - US12448X2018 - Common Stock - Currency: USD

22.21  +0.09 (+0.41%)

After market: 22.25 +0.04 (+0.18%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BYRN. BYRN was compared to 67 industry peers in the Aerospace & Defense industry. BYRN has an excellent financial health rating, but there are some minor concerns on its profitability. BYRN is valued quite expensive, but it does show an excellent growth. These ratings would make BYRN suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BYRN had positive earnings in the past year.
In the past year BYRN has reported a negative cash flow from operations.
In the past 5 years BYRN reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: BYRN reported negative operating cash flow in multiple years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

BYRN has a Return On Assets of 19.09%. This is amongst the best in the industry. BYRN outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 24.59%, BYRN belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
With an excellent Return On Invested Capital value of 12.65%, BYRN belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
Industry RankSector Rank
ROA 19.09%
ROE 24.59%
ROIC 12.65%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

Looking at the Profit Margin, with a value of 14.28%, BYRN belongs to the top of the industry, outperforming 89.55% of the companies in the same industry.
BYRN has a Operating Margin of 9.60%. This is in the better half of the industry: BYRN outperforms 62.69% of its industry peers.
The Gross Margin of BYRN (61.88%) is better than 97.01% of its industry peers.
In the last couple of years the Gross Margin of BYRN has grown nicely.
Industry RankSector Rank
OM 9.6%
PM (TTM) 14.28%
GM 61.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BYRN is creating some value.
Compared to 1 year ago, BYRN has more shares outstanding
Compared to 5 years ago, BYRN has more shares outstanding
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BYRN has an Altman-Z score of 18.83. This indicates that BYRN is financially healthy and has little risk of bankruptcy at the moment.
BYRN has a better Altman-Z score (18.83) than 97.01% of its industry peers.
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.83
ROIC/WACC1.21
WACC10.43%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.63 indicates that BYRN has no problem at all paying its short term obligations.
BYRN's Current ratio of 3.63 is amongst the best of the industry. BYRN outperforms 80.60% of its industry peers.
BYRN has a Quick Ratio of 1.53. This is a normal value and indicates that BYRN is financially healthy and should not expect problems in meeting its short term obligations.
BYRN has a Quick ratio (1.53) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.63
Quick Ratio 1.53
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1450.00% over the past year.
Looking at the last year, BYRN shows a very strong growth in Revenue. The Revenue has grown by 73.55%.
The Revenue has been growing by 147.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)73.55%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%40.63%

3.2 Future

Based on estimates for the next years, BYRN will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.26% on average per year.
Based on estimates for the next years, BYRN will show a quite strong growth in Revenue. The Revenue will grow by 18.79% on average per year.
EPS Next Y-42.42%
EPS Next 2Y11.45%
EPS Next 3Y12.26%
EPS Next 5YN/A
Revenue Next Year34.98%
Revenue Next 2Y28.09%
Revenue Next 3Y30.28%
Revenue Next 5Y18.79%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.82, which means the current valuation is very expensive for BYRN.
Based on the Price/Earnings ratio, BYRN is valued a bit cheaper than the industry average as 68.66% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BYRN to the average of the S&P500 Index (27.25), we can say BYRN is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 28.84, the valuation of BYRN can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BYRN indicates a somewhat cheap valuation: BYRN is cheaper than 64.18% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.80. BYRN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 35.82
Fwd PE 28.84
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BYRN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.11
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The decent profitability rating of BYRN may justify a higher PE ratio.
A more expensive valuation may be justified as BYRN's earnings are expected to grow with 12.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.45%
EPS Next 3Y12.26%

0

5. Dividend

5.1 Amount

BYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (7/31/2025, 8:07:44 PM)

After market: 22.25 +0.04 (+0.18%)

22.21

+0.09 (+0.41%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-10 2025-07-10/bmo
Earnings (Next)10-07 2025-10-07/bmo
Inst Owners59.39%
Inst Owner Change0.34%
Ins Owners19.33%
Ins Owner Change-0.95%
Market Cap504.17M
Analysts84
Price Target38.38 (72.81%)
Short Float %22.87%
Short Ratio6.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.56%
Min EPS beat(2)21.04%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)104.71%
Min EPS beat(4)21.04%
Max EPS beat(4)254.68%
EPS beat(8)6
Avg EPS beat(8)-36.83%
EPS beat(12)8
Avg EPS beat(12)-9.3%
EPS beat(16)9
Avg EPS beat(16)-27.67%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)1.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.75%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)1.52%
Revenue beat(8)4
Avg Revenue beat(8)4.49%
Revenue beat(12)4
Avg Revenue beat(12)-1.24%
Revenue beat(16)5
Avg Revenue beat(16)-1.7%
PT rev (1m)4.88%
PT rev (3m)5.61%
EPS NQ rev (1m)-29.28%
EPS NQ rev (3m)-30.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.69%
Revenue NQ rev (1m)-1.2%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.51%
Valuation
Industry RankSector Rank
PE 35.82
Fwd PE 28.84
P/S 4.87
P/FCF N/A
P/OCF N/A
P/B 8.38
P/tB 9.22
EV/EBITDA 41.11
EPS(TTM)0.62
EY2.79%
EPS(NY)0.77
Fwd EY3.47%
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS4.56
BVpS2.65
TBVpS2.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.09%
ROE 24.59%
ROCE 16.01%
ROIC 12.65%
ROICexc 16%
ROICexgc 18%
OM 9.6%
PM (TTM) 14.28%
GM 61.88%
FCFM N/A
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score6
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 289.39%
Cap/Sales 5.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.63
Quick Ratio 1.53
Altman-Z 18.83
F-Score6
WACC10.43%
ROIC/WACC1.21
Cap/Depr(3y)202.29%
Cap/Depr(5y)309.93%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y-42.42%
EPS Next 2Y11.45%
EPS Next 3Y12.26%
EPS Next 5YN/A
Revenue 1Y (TTM)73.55%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%40.63%
Revenue Next Year34.98%
Revenue Next 2Y28.09%
Revenue Next 3Y30.28%
Revenue Next 5Y18.79%
EBIT growth 1Y407.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year234.99%
EBIT Next 3Y81.16%
EBIT Next 5Y53.44%
FCF growth 1Y-58.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.81%
OCF growth 3YN/A
OCF growth 5YN/A